• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News

News · January 20, 2011

James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals

Additional Management Team Announcement with Promotion of Robert Silverman January 19, 2011, Lexington, MA -- Concert Pharmaceuticals, Inc. announced today the appointment of James E. Shipley, M.D., …

News · January 17, 2011

Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium

PITTSBURGH, Jan. 17, 2011 /PRNewswire/ -- In a new study in which Precision Therapeutics' Multi-Gene Predictors (MGPs) were independently validated by investigators at US Oncology and MD Anderson, …

News · January 13, 2011

New Patents Continue to issue for Concert Pharmaceuticals Deuterium Chemistry Intellectual Property

January 13, 2011 Lexington, MA –- Concert Pharmaceuticals, Inc. announced the issuance of several new patents relating to specific compounds derived from its DCE Platform™ (Deuterated Chemical Entity …

News · January 7, 2011

Anchor Therapeutics Achieves Milestone in GPCR Collaboration

-- Significant Progress Over First Four Months of Joint Research -- Cambridge, MA - January 7, 2011 - Anchor Therapeutics today announced that it has successfully completed the first stage of its …

News · January 5, 2011

EUSA Pharma Announces Priority Review Status for ERWINAZE® BLA

Langhorne, PA and Oxford, UK – 5 January 2011 EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its …

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 48
  • Go to page 49
  • Go to page 50

Primary Sidebar

Secondary Sidebar

Additional News

Egg Medical hatches technology to shield health care workers from radiation

March 29, 2022

Egg Medical hatches $13M VC funding

March 15, 2022

Egg Medical, Inc., Closes on $13 million Financing

March 3, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

February 8, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

February 1, 2022

  • in

Copyright © 2022 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact